04.02.2025
В. Н. Перегоедова; И. К. Богомолова; Е. В. Рацина
22.09.2024
И. К. Богомолова; В. Н. Перегоедова
(COVID-19).
Study objective: to study blood serum TGF-β1 content in children with new coronavirus
05.08.2024
А. Г. Опарина; А Б. Долина; И. К. Богомолова
CHARACTERISTICS OF MYOCARDIAL DAMAGE DURING COVID-19 IN CHILDREN: REMOTE CONSEQUENCES
04.08.2024
И. К. Богомолова; А. А. Бабкин; В. Н. Перегоедова; В. А. Щербак
-TAC) in blood serum, transforming growth factor TGF-β1. The severity and outcomes of COVID-19
30.07.2024
И. К. Богомолова; О. Н. Емельянова; Н. В. Левченко; И. В. Нардина
-2019) and during the pandemic of the new coronavirus infection COVID-19 (2020-2021) were studied
11.04.2024
В. Н. Перегоедова; И. К. Богомолова
form of COVID-19, second – 54 children with mild form and third – 28 patients with moderate form
05.04.2024
И. К. Богомолова; А. А. Бабкин; В. Н. Перегоедова
characteristics of children’s health depending on the form of severity of the new coronavirus infection (COVID-19
11.01.2024
Е. П. Батаева; И. К. Богомолова; А. Б. Долина; А. Г. Опарина
Kidney damage in children with COVID-19 (clinical observation)
